- >
- News & Events
- >
- Press Releases
Press Releases
Page 2 of 29
Onxeo will publish its annual results on April 21, 2021
The Annual General Meeting will be held on June 10, 2021 Paris (France), March 24, 2021 – 6 pm CET […]
Tags: Financials & Corporate
03/24/2021
Onxeo Launches a Rights Issue to accelerate its R&D programs
This transaction will secure the financing of the strategy and the resources necessary to achieve key clinical milestones until at […]
03/10/2021
Onxeo Enters Clinical Research Agreement with Institut Curie to Conduct a phase 1b/2 Clinical Trial of AsiDNA™ in combination with radiotherapy for Treatment of High-Grade Glioma Relapse in Children
This study is supported by a grant from the European Fight Kids Cancer program[1] Paris (France), February 4, 2021 […]
02/04/2021
Onxeo publishes Letter to Shareholders and provides update on its developments
Paris (France), February 2, 2021 – 9 pm CET – Onxeo S.A. (Euronext Growth: ALONX; Nasdaq First North: ONXEO), a […]
02/02/2021
Onxeo Obtains Non-Dilutive Financing of 5 Million Euros in the Form of State Guaranteed Loans
This financing extends the Company’s cash horizon to the 3rd quarter of 2022 Paris (France), January 28, 2021 – […]
01/28/2021
Onxeo to Attend Key Investor and Scientific Conferences
Paris (France), January 11, 2021 – 7:00 am CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]
01/11/2021
2020 – Full-year report on the liquidity contract
2020 Full-year report on the liquidity contract
01/08/2021
Onxeo Announces its Financial Agenda for 2021
Paris (France), January 7, 2021 – 6 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]
01/07/2021
Page 2 of 29